| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant C Wiebe, IW Gibson, TD Blydt-Hansen, M Karpinski, J Ho, LJ Storsley, ... American journal of transplantation 12 (5), 1157-1167, 2012 | 1077 | 2012 |
| Class II HLA epitope matching—a strategy to minimize de novo donor-specific antibody development and improve outcomes C Wiebe, D Pochinco, TD Blydt-Hansen, J Ho, PE Birk, M Karpinski, ... American journal of transplantation 13 (12), 3114-3122, 2013 | 387 | 2013 |
| Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody C Wiebe, IW Gibson, TD Blydt-Hansen, D Pochinco, PE Birk, J Ho, ... American Journal of Transplantation 15 (11), 2921-2930, 2015 | 379 | 2015 |
| Urinary, plasma, and serum biomarkers’ utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis J Ho, N Tangri, P Komenda, A Kaushal, M Sood, R Brar, K Gill, S Walker, ... American journal of kidney diseases 66 (6), 993-1005, 2015 | 300 | 2015 |
| Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development C Wiebe, DN Rush, TE Nevins, PE Birk, T Blydt-Hansen, IW Gibson, ... Journal of the American Society of Nephrology 28 (11), 3353-3362, 2017 | 239 | 2017 |
| Mass spectrometry–based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study J Ho, M Lucy, O Krokhin, K Hayglass, E Pascoe, G Darroch, D Rush, ... American Journal of Kidney Diseases 53 (4), 584-595, 2009 | 181 | 2009 |
| HLA-DR/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity C Wiebe, V Kosmoliaptsis, D Pochinco, IW Gibson, J Ho, PE Birk, ... American journal of transplantation 19 (6), 1708-1719, 2019 | 168 | 2019 |
| Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury M James, J Bouchard, J Ho, S Klarenbach, JP LaFrance, C Rigatto, ... American Journal of Kidney Diseases 61 (5), 673-685, 2013 | 162 | 2013 |
| Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival C Wiebe, AJ Gareau, D Pochinco, IW Gibson, J Ho, PE Birk, ... American Journal of Transplantation 17 (3), 703-711, 2017 | 97 | 2017 |
| Early reversible acute kidney injury is associated with improved survival in septic shock MM Sood, LA Shafer, J Ho, M Reslerova, G Martinka, S Keenan, S Dial, ... Journal of Critical Care 29 (5), 711-717, 2014 | 96 | 2014 |
| Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury J Ho, M Reslerova, B Gali, PW Nickerson, DN Rush, MM Sood, J Bueti, ... American journal of kidney diseases 59 (2), 196-201, 2012 | 91 | 2012 |
| Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis J Ho, DN Rush, M Karpinski, L Storsley, IW Gibson, J Bestland, A Gao, ... Transplantation 92 (8), 878-882, 2011 | 80 | 2011 |
| Detection of clinical and subclinical tubulo-interstitial inflammation by the urinary CXCL10 chemokine in a real-life setting P Hirt-Minkowski, P Amico, J Ho, A Gao, J Bestland, H Hopfer, J Steiger, ... American Journal of Transplantation 12 (7), 1811-1823, 2012 | 77 | 2012 |
| Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass J Ho, M Reslerova, B Gali, A Gao, J Bestland, DN Rush, PW Nickerson, ... Clinical Journal of the American Society of Nephrology 6 (10), 2340-2346, 2011 | 75 | 2011 |
| Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation TD Blydt-Hansen, IW Gibson, A Gao, B Dufault, J Ho Transplantation 99 (4), 797-804, 2015 | 70 | 2015 |
| Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts J Ho, DN Rush, IW Gibson, M Karpinski, L Storsley, J Bestland, W Stefura, ... Transplantation 90 (4), 394-400, 2010 | 65 | 2010 |
| Pre-transplant AT1R antibodies correlate with early allograft rejection AJ Gareau, C Wiebe, D Pochinco, IW Gibson, J Ho, DN Rush, ... Transplant immunology 46, 29-35, 2018 | 62 | 2018 |
| The negative impact of T cell–mediated rejection on renal allograft survival in the modern era C Rampersad, R Balshaw, IW Gibson, J Ho, J Shaw, M Karpinski, ... American Journal of Transplantation 22 (3), 761-771, 2022 | 56 | 2022 |
| Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection C Wiebe, DN Rush, IW Gibson, D Pochinco, PE Birk, A Goldberg, ... American journal of transplantation 20 (9), 2499-2508, 2020 | 54 | 2020 |
| Regular physical activity and exercise therapy in end-stage renal disease: how should we move forward CJ Bohm, J Ho, TA Duhamel J Nephrol 23 (3), 235-243, 2010 | 47 | 2010 |
